Panvax (influenza A (H1N1) 2009 monovalent vaccine) / CSL Behring - LARVOL DELTA

Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants. (PubMed, Biochem Biophys Res Commun) - "Post-vaccination, this approach elicited effective immunity against multiple SARS-CoV-2 variants, including Delta and Omicron, and demonstrated good safety. This study suggests a novel direction for the design of broadly protective vaccines."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases